QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NYSEARCA:PGM

iPath Series B Bloomberg Platinum Subindex Total Return ETN (PGM) Price, Holdings, & News

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)
Free PGM Stock Alerts
$49.41
0.00 (0.00%)
(As of 06/14/2023)
Compare
Today's Range
$49.41
▼
$49.41
50-Day Range
$49.41
▼
$49.41
52-Week Range
$37.71
▼
$54.66
Volume
N/A
Average Volume
314 shs
Market Capitalization
$5.44 million
Assets Under Management
N/A
Dividend Yield
0.00%
Net Expense Ratio
0.45%
Stock Analysis
Stock Analysis

PGM Stock Price History

PGM ETF News Headlines

August 7, 2023 | finance.yahoo.com
JJG - iPath Series B Bloomberg Grains Subindex Total Return ETN
April 24, 2023 | finance.yahoo.com
ETFs to Ride the Platinum Rally
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
April 18, 2023 | seekingalpha.com
COW iPath® Series B Bloomberg Livestock Subindex Total Return ETN
January 13, 2023 | nasdaq.com
Powerful Platinum Pertinent in 2023 Commodities Conversation
May 18, 2022 | finance.yahoo.com
3 Platinum ETFs for Q3 2022
March 30, 2022 | finance.yahoo.com
PureGold Reports Fourth Quarter and Annual 2021 Operating and Financial Results
March 29, 2022 | finance.yahoo.com
iPath Series B Bloomberg Platinum Subindex Total Return ETN (PGM)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 24, 2022 | finance.yahoo.com
Why The 50% Return On Capital At Platina Resources (ASX:PGM) Should Have Your Attention
See More Headlines
Receive PGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iPath Series B Bloomberg Platinum Subindex Total Return ETN and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Barclays Capital
Fund Name
iPath Series B Bloomberg Platinum Subindex Total Return ETN
Tax Classification
Exchange-Traded Note
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PGM
Inception Date
1/17/2018
Fund Manager
N/A
Web
www.barclays.co.uk
Phone
442035554619

Fund Focus

Asset Class
Commodities
Benchmark
Bloomberg Platinum Subindex Total Return
Category
Precious Metals
Focus
Platinum
Development Level
Blended Development
Region
Global
Number of Holdings
0

Fund Statistics

Assets Under Management
$0.00
Average Daily Volume
$811.00
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Outstanding Shares
110,000
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Ad Behind the Markets
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

iPath Series B Bloomberg Platinum Subindex Total Return ETN Expenses

TypePGMPlatinum ETFsCommodities ETFsNYSEARCA ETFsAll ETFs
Management Fee0.00%0.55%0.66%0.50%0.51%
Other Expenses0.00%0.00%0.27%0.64%0.58%
Total Expense0.00%0.55%0.77%0.74%0.70%
Fee Waiver0.00%0.00%-0.18%-0.68%-0.57%
Net Expense0.45%0.52%0.70%0.58%0.58%

iPath Series B Bloomberg Platinum Subindex Total Return ETN (PGM)

Full Holdings Details

PGM ETF - Frequently Asked Questions

How have PGM shares performed in 2024?

iPath Series B Bloomberg Platinum Subindex Total Return ETN's stock was trading at $49.41 at the beginning of 2024. Since then, PGM shares have increased by 0.0% and is now trading at $49.41.
View the best growth stocks for 2024 here.

What does PGM invest in?

iPath Series B Bloomberg Platinum Subindex Total Return ETN is a commodities fund issued by Barclays Capital. PGM focuses on platinum investments and follows the Bloomberg Platinum Subindex Total Return.

How do I buy shares of iPath Series B Bloomberg Platinum Subindex Total Return ETN?

Shares of PGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:PGM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative